The next pandemic may not begin with panic — but with complacency. Experts now warn the world is less prepared for major outbreaks than before COVID, as trust erodes, funding declines, and new biological risks emerge. From Disease X scenarios to AI biosecurity fears, humanity’s health moat may be dangerously underfunded.

Read entire article

Ticks are tiny, ancient arachnids capable of causing massive financial and medical damage. From Lyme disease and Powassan virus to Alpha-gal syndrome — the bizarre tick-triggered meat allergy affecting nearly 500,000 Americans — this FUNanc1al deep dive explores the real costs, creepy biology, prevention strategies, and why a bottle of DEET may be one of the best investments you ever make.

Read entire article

After more than two decades of measles elimination, the United States is now at serious risk of losing that status in 2026. With outbreaks spreading across 45 states and vaccination rates slipping below herd-immunity thresholds, one of modern medicine’s greatest victories may be unraveling in real time. 🔴💉

Read entire article

Hantavirus may be one of the deadliest viruses most people barely understand. While the 2026 cruise ship outbreak triggered pandemic-era fears, the biological reality is very different from COVID. Here’s why Hantavirus is terrifyingly lethal, why experts say global pandemic risk remains low, and how Moderna’s mRNA platform could become one of the biggest biotech stories of the decade. 🐁💉

Read entire article

Vaccines may be the highest-ROI investment in human history—but what happens when trust in them declines? As skepticism rises globally, so does the risk of disease resurgence. Here’s the audit.

Read entire article